key: cord-0878781-n5i58i9n
authors: Yeh, Ting-Kuang; Li, Zong-Hao; Huang, Yao-Ting; Liu, Po-Yu
title: COVID-19 Associated Bacteremia with Chryseobacterium indologenes Co-Harboring bla(IND-2), bla(CIA) and bla(CcrA)
date: 2022-01-20
journal: Infect Drug Resist
DOI: 10.2147/idr.s347066
sha: 07cd3eca86c8e4f08c92353e5c2035624e2045ce
doc_id: 878781
cord_uid: n5i58i9n

We report a COVID-19 case with carbapenem resistant Chryseobacterium indologenes bacteremia. Whole genome sequencing identified the presence of bla(IND-2), bla(CIA) and bla(CcrA). To our knowledge, this is the first report of Chryseobacterium indologenes complicating COVID-19 and the detection of bla(CcrA) in C. indologenes. The presence of bla(CcrA) in Chryseobacterium was overlooked previously may related to substantial sequence divergence with the original allele in Bacteroides fragilis. Antimicrobial resistance (AMR) is a challenge to global health in the age of COVID-19 pandemic. Further study and surveillance of underlying mechanisms is needed.

revealed the C. indologenes isolate was resistant to piperacillin/tazobactam, ceftazidime, ceftriaxone, cefepime, imipenem, amikacin, gentamicin, ciprofloxacin, tigecycline ( Table 1 ). The report was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Taichung Veterans General Hospital (CE20261A).

The whole genome of this C. indologenes strain (designated strain as C205) was sequenced using Nanopore sequencing (GridIon, R9.4 flowcells). The genome was assembled by Flye and the errors were corrected by Homopolish. The antibiotic resistant genes were annotated by NCBI AMRFinderPlus and Hidden Markov Models (HMM) search was used. Whole-genome sequencing, assembly, and resistome analysis identified two metallo βlactamases (bla IND-2 and bla CcrA ) and one extended-spectrum β-lactamase (bla CIA ) in the chromosome ( Figure 1 ). All the sequencing data have been deposited in GenBank under Accession CP085529. bla CcrA in Chryseobacterium has not been reported previously. Further investigated did not identify mobile genetic elements at either upstream nor downstream of the bla CcrA in C. indologenes C205, suggesting a possibility of vertical transmission. Subsequent search of bla CcrA in the NCBI database confirms it was also presented in the chromosomes of other C. indologenes strains and many species of Chryseobacterium (e.g., C. lactis, C. phosphatilyticum, and C. carnipullorum). No C. indologenes growth in the sputum culture of this case. Indwelling central venous catheter was considered as risk factor and infection source of C. indologenes bacteremia in this case. The patient was treated with trimethoprim-sulfamethoxazole (TMP-SMX) and discharged under clinical stable condition.

To the best of our knowledge, this is the first report COVID-19 associated bacteremia with C. indologenes coharboring bla IND-2 , bla CIA and bla CcrA . Considering secondary bacterial co-infections with AMR attributed to increasing mortality during previous pandemics, 2 COVID-19 patients superimposed bacterial infection with MDR pathogen deserved more investigation.

The bla CcrA has not been reported in Chryseobacterium. The CcrA, belonging to metallo-β-lactamase, was initially identified in a clinical isolate of Bacteroides fragilis TAL3636. 7 CcrA enzyme strongly hydrolyzed cefoxitin and carbapenems, but not the monocyclic β-lactam. CcrA enzyme was inhibited by tazobactam but not clavulanic acid or sulbactam. Our investigation indicated the bla CcrA is not only found in our strain but also vertically transferred in many species of Chryseobacterium. The presence of bla CcrA in Chryseobacterium was overlooked in previous studies because of substantial sequence divergence with the original allele in B. fragilis. Therefore, the homology-based search of antibiotic-resistance genes would miss this β-lactamase.

In conclusion, we reported the first case of co-harboring bla IND-2 , bla CIA and bla CcrA in a C. indologenes strain isolated from a COVID-19 patient with bacteremia. The interrelationship between SRAS-CoV-2 and AMR represents a public health concern globally.

All authors made a significant contribution to the work reported during the conception, study design, execution, data acquisition, analysis, interpretation, drafting, and revising, or critically reviewing the article. All authors gave their final 

All authors report no conflicts of interest relevant to this work. 

Secondary infections in hospitalized COVID-19 patients: Indian experience

The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics

Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents

Chryseobacterium indologenes: an emerging infection in the USA

Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program

Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in

Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636

Infection and Drug Resistance

Infection and Drug Resistance is an international, peer-reviewed open-access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance. The journal is specifically concerned with the epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use